Addition of the cytoplasmic domain of CD28, CD134 or CD137 to CD3-ζ-containing CARs can lead to increased cytokine production in response to tumor-associated antigens (TAA) and an enhanced ability of adoptively transferred T cells to mediate tumor regression.13, 14, 15, 16. This evidence concerns the gene TNFRSF9 and neoplasm.